# TASCENSO ODT
> **NDA214962** · New Drug Application · Sponsor: CYCLE · Approved 2022-12-09
## Drug
- **FDA Application Number:** NDA214962
- **Application type:** New Drug Application
- **Brand name:** TASCENSO ODT
- **Generic name:** FINGOLIMOD LAURYL SULFATE
- **Active ingredients:** FINGOLIMOD LAURYL SULFATE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CYCLE
- **Manufacturer:** Cycle Pharmaceuticals Ltd
- **First approval:** 2022-12-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214962)
---
*AI Analytics · CC0 1.0*